Stay updated on NVG-111 in ROR1+ Malignancies Clinical Trial

Sign up to get notified when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NVG-111 in ROR1+ Malignancies Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page content appears unchanged between screenshots; sections such as Study Overview, Eligibility Criteria, and Contacts remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:31:52.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    36 days ago
    Change Detected
    Summary
    Summary: The page updates its version from v3.1.0 to v3.2.0, adds a government-operating-status notice and a new clinical term (malignant lymphoma, large B-cell, diffuse), and retains the NIH Clinical Center operating info. The old version reference (v3.1.0) was removed.
    Difference
    4%
    Check dated 2025-10-05T12:52:19.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Updates version from v3.0.2 to v3.1.0 and adds new contact details and phone number; no substantive changes to core content detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:27:40.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; 'Back to Top' removed. No changes to core content, pricing, stock, or time-slot availability.
    Difference
    0.2%
    Check dated 2025-09-14T00:11:34.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T17:59:34.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as various types of lymphomas and lung diseases, while removing several previous terms related to locations and specific diseases.
    Difference
    8%
    Check dated 2025-08-30T15:26:36.000Z thumbnail image

Stay in the know with updates to NVG-111 in ROR1+ Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.